reviewSeminars in Cancer BiologyNov 26, 2017GREEN OA

Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy

LOLais OsmaniFBFrederic B. AskinEGEdward GabrielsonQKQing Kay Li

Johns Hopkins University

Indexed incrossref

Abstract

No abstract available for this paper.

Citation impact

825
total citations
FWCI
37.74
Percentile
100%
References
39
Citations per year

Authors

4

Topics & keywords

Topics
Keywords
  • Lung cancer
  • Medicine
  • Targeted therapy
  • Immunotherapy
  • Oncology
  • Internal medicine
  • Cancer
  • Carcinoma
No related works found for this paper.